192 related articles for article (PubMed ID: 16332723)
1. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
3. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women.
Wen W; Gao YT; Shu XO; Yu H; Cai Q; Smith JR; Zheng W
Int J Cancer; 2005 Jan; 113(2):307-11. PubMed ID: 15386404
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of insulin-like growth factor-1 CA repeat polymorphism on breast cancer risk along with race: a meta-analysis.
He B; Xu Y; Pan Y; Li R; Gao T; Song G; Gu L; Nie Z; Chen L; Wang S
Gene; 2013 Aug; 525(1):92-8. PubMed ID: 23628798
[TBL] [Abstract][Full Text] [Related]
7. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.
Missmer SA; Haiman CA; Hunter DJ; Willett WC; Colditz GA; Speizer FE; Pollak MN; Hankinson SE
Int J Cancer; 2002 Jul; 100(3):332-6. PubMed ID: 12115549
[TBL] [Abstract][Full Text] [Related]
8. Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women.
Fehringer G; Ozcelik H; Knight JA; Paterson AD; Boyd NF
Breast Cancer Res Treat; 2009 Jul; 116(2):413-23. PubMed ID: 18785005
[TBL] [Abstract][Full Text] [Related]
9. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor polymorphisms and colorectal cancer risk.
Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1204-11. PubMed ID: 15894673
[TBL] [Abstract][Full Text] [Related]
11. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
[TBL] [Abstract][Full Text] [Related]
12. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
13. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
[TBL] [Abstract][Full Text] [Related]
15. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer.
Zecevic M; Amos CI; Gu X; Campos IM; Jones JS; Lynch PM; Rodriguez-Bigas MA; Frazier ML
J Natl Cancer Inst; 2006 Jan; 98(2):139-43. PubMed ID: 16418517
[TBL] [Abstract][Full Text] [Related]
16. Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
Henningson M; Bågeman E; Sandberg T; Borg A; Olsson H; Jernström H
Fam Cancer; 2007; 6(4):445-52. PubMed ID: 17484040
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic CA repeat length in insulin-like growth factor 1 and risk of breast cancer in Iranian women.
Javadi M; Hematti S; Tavassoli M
Med Oncol; 2012 Jun; 29(2):516-20. PubMed ID: 21484083
[TBL] [Abstract][Full Text] [Related]
19. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic CA repeats in the IGF-I gene and breast cancer.
Yu H; Li BD; Smith M; Shi R; Berkel HJ; Kato I
Breast Cancer Res Treat; 2001 Nov; 70(2):117-22. PubMed ID: 11768601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
